A GLP-1 journey encompasses the complete treatment experience with glucagon-like peptide-1 receptor agonistsmedications FDA-approved for type 2 diabetes and chronic weight management
Understanding the precise mechanism by which GLP-1 agonists work is essential when evaluating whether other compounds, such as berberine, share similar pharmacological properties
Disguised Alpha 5-Amino-1MQ is made for researchers who expect more than a generic small-molecule listing
Serial analyses of the metabolic profile showed consistently high HbA1c levels and body weight loss among GLP-1 RAs users
In addition to expanded indications, pharmaceutical companies are developing next-generation therapies that combine GLP-1 activity with other mechanisms
Fucoidan, a group of sulfated polysaccharides from brown algae, acts as an SIRT3 activator, inhibiting cellular senescence and the harmful effects of senescence-associated secretory phenotypes (SASPs) 189,190